The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.51BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Revenue (TTM)
828.24MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Profit Margin
0.27%
Updated Oct 27, 2026
Beta
3.01x
vs all stocks
Updated Oct 27, 2026
52-Week Change
176.47%
vs all stocks
Updated Oct 27, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Market Capitalization
1.51BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Enterprise Value
1.80BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Forward P/E
22.91x
Updated Oct 27, 2026
Price to Sales (TTM)
1.72x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 1.82×.Updated Oct 27, 2026
Price to Book (MRQ)
3.76x
Updated Oct 27, 2026
Enterprise to Revenue
2.17x
Updated Oct 27, 2026
Enterprise to EBITDA
44.54x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 45.54×.Updated Oct 27, 2026
Gross Margin
35.72%
Updated Oct 27, 2026
Profit Margin
0.27%
Updated Oct 27, 2026
Operating Margin
-2.07%
Updated Oct 27, 2026
Return on Assets (TTM)
-0.86%
Updated Oct 27, 2026
Return on Equity (TTM)
0.59%
Updated Oct 27, 2026
Revenue (TTM)
828.24MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Revenue per Share (TTM)
26.52USDUpdated Oct 27, 2026
Quarterly Revenue Growth
22.20%
Updated Oct 27, 2026
Gross Profit (TTM)
308.43MUSD
vs all stocks (USD)
Updated Oct 27, 2026
EBITDA (TTM)
39.56MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Net Income (TTM)
2.26MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Quarterly Earnings Growth (YoY)
22.16%
Updated Oct 27, 2026
Operating Cash Flow (TTM)
98.39MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Levered Free Cash Flow (TTM)
72.43MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 27, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Payout Ratio
0.00%
Updated Oct 27, 2026
Revenue
753.82MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
458.77MUSDFY2025 · Dec 31, 2025
Gross Profit
295.05MUSDFY2025 · Dec 31, 2025
Operating Income
-14.37MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-16.59MUSDFY2025 · Dec 31, 2025
Income Tax Expense
-3.68MUSDFY2025 · Dec 31, 2025
Net Income
-12.91MUSDFY2025 · Dec 31, 2025
EBIT
-14.56MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
38.12MUSDFY2025 · Dec 31, 2025
Research & Development
132.52MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
176.90MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
2.03MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-0.4300USDFY2025 · Dec 31, 2025
EPS (Diluted)
-0.4300USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
30.00MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
30.00MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-12.91MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
102.99MUSDFY2025 · Dec 31, 2025
Free Cash Flow
80.73MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
103.16MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-12.91MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
53.76MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
-2.13MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
52.33MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
4.77MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-3.96MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
13.07MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-1.95MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-22.26MUSDFY2025 · Dec 31, 2025
Net Intangibles (CF)
0.00USDFY2025 · Dec 31, 2025
Net Acquisitions
361.00KUSDFY2025 · Dec 31, 2025
Purchase of Investments
-16.13MUSDFY2025 · Dec 31, 2025
Sale of Investments
9.65MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-28.38MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
28.50MUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-54.71MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-2.97MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-29.18MUSDFY2025 · Dec 31, 2025
Shares Outstanding
32.18MSharesUpdated Oct 27, 2026
Float Shares
29.02MSharesUpdated Oct 27, 2026
Shares Short
4.72MSharesUpdated Oct 27, 2026
Short Ratio
4.74days
vs all stocks
Updated Oct 27, 2026
Short % of Shares Outstanding
15.91%
vs all stocks
Updated Oct 27, 2026
% Held by Insiders
3.22%
vs all stocks
Updated Oct 27, 2026
% Held by Institutions
102.92%
vs all stocks
Updated Oct 27, 2026
Total Cash (MRQ)
174.36MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Cash per Share (MRQ)
5.42USDUpdated Oct 27, 2026
Total Debt (MRQ)
554.42MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Debt to Equity (MRQ)
1.47x
Updated Oct 27, 2026
Current Ratio (MRQ)
2.04x
Updated Oct 27, 2026
Book Value per Share (MRQ)
11.75USDUpdated Oct 27, 2026
Total Assets
1.05BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
219.06MUSDFY2025 · Dec 31, 2025
Total Liabilities
652.65MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
833.57MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
498.59MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
154.07MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
102.79MUSDFY2025 · Dec 31, 2025
Other Short-term Investments
8.48MUSDFY2025 · Dec 31, 2025
Accounts Receivable
34.55MUSDFY2025 · Dec 31, 2025
Accounts Payable
42.60MUSDFY2025 · Dec 31, 2025
Short-term Debt
11.57MUSDFY2025 · Dec 31, 2025
Deferred Revenue
13.06MUSDFY2025 · Dec 31, 2025
Long-term Debt
468.58MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
555.00KUSDFY2025 · Dec 31, 2025
Common Stock (Book)
31.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
-84.33MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
399.97MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
12.50USDUpdated Oct 27, 2026
52-Week High
79.08USDUpdated Oct 27, 2026
52-Week Change
176.47%
vs all stocks
Updated Oct 27, 2026
Beta
3.01x
vs all stocks
Updated Oct 27, 2026
50-Day MA
51.84USDUpdated Oct 27, 2026
200-Day MA
40.18USDUpdated Oct 27, 2026
Avg 10-Day Volume
836.97KSharesUpdated Oct 27, 2026
Avg 30-Day Volume
889.01KSharesUpdated Oct 27, 2026
Diluted EPS (TTM)
-0.3400USDUpdated Oct 27, 2026
Other Income / Expense
-194.00KUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.02: grey zoneSignificant
Altman Z-Score: 2.02
High earnings qualityNotable
Earnings Quality Score: 2.34
Supply Chain
Downstream position: depends on 18 industries, supplies 6Notable
Outgoing: 6.00Incoming: 18.00
High connectivity hub: 24 industry connectionsNotable
Total Connections: 24.00
Scale
Market cap is $1.51B, above the global median of $1.14BNotable
Market cap (USD): 1,508,957,149Global Median: 1,137,180,293.291
Revenue is $828.24M, above the global median of $566.17MNotable